Software to support breast cancer risk assessment

WRRisk is our clinical decision support software for breast cancer risk assessment.

How it Works


Health information is captured digitally to reduce manual transcription of data saving time.


Tailored specifically to each individual patient, our risk rating allows a means for providing personalized medical care.


Built on top of existing well-established models for breast cancer risk.

Details to Note

PACS Integrated

Displays risk score & WRDensity data on the same scorecard

Enables a timely and personalized determination of breast cancer risk

WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation.

Equips patients and providers with the information they need. WRRisk estimates 10-year and lifetime-risk as well as risk-based on runner-up density.

Find out how our products can help your business drive compliance, improve patient outcomes, and increase revenue.


1  Whiterabbit data on file.

2  Artificial intelligence and consistency in patient care: a large-scale, longitudinal study of breast density assessment.

3 Whiterabbit data on file.

4 Holley, S., Cordoza, D., Matthews, T. P., & Gastounioti, A. (2022, December 3). Artificial intelligence and consistency in patient care: A large-scale, longitudinal study of breast density assessment [Conference Presentation].

1 Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017;3(9):1228–1236.

1 Eligible patient is defined as any woman who has a screening mammogram within the previous five years.

2 Moorman S, Pujara A, Sakala M, et al. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening. American Journal of Roentgenology 2021 217:1, 40-47